Your browser doesn't support javascript.
loading
Mitral annular disjunction in idiopathic ventricular fibrillation patients: just a bystander or a potential cause?
Verheul, L M; Guglielmo, M; Groeneveld, S A; Kirkels, F P; Scrocco, C; Cramer, M J; Bootsma, M; Kapel, G F L; Alings, M; Evertz, R; Mulder, B A; Prakken, N H J; Balt, J C; Volders, P G A; Hirsch, A; Yap, S C; Postema, P G; Nijveldt, R; Velthuis, B K; Behr, E R; Wilde, A A M; Hassink, R J.
Afiliação
  • Verheul LM; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Guglielmo M; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Groeneveld SA; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Kirkels FP; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Scrocco C; Cardiology Research Section, St. George University of London, Cranmer Terrace, London SW17 0RE, UK.
  • Cramer MJ; St George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK.
  • Bootsma M; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Kapel GFL; Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Alings M; Medisch Spectrum Twente, Koningstraat 1, 7512 KZ Enschede, The Netherlands.
  • Evertz R; Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.
  • Mulder BA; Radboud UMC, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
  • Prakken NHJ; University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Balt JC; University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Volders PGA; St. Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands.
  • Hirsch A; Maastricht University Medical Center+, Peter Debyelaan 25, 6229 HX Maastricht, The Netherlands.
  • Yap SC; Thorax Center, Cardiovascular Institute, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Postema PG; Thorax Center, Cardiovascular Institute, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Nijveldt R; Department of Cardiology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Velthuis BK; Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands.
  • Behr ER; Radboud UMC, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
  • Wilde AAM; University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Hassink RJ; Cardiology Research Section, St. George University of London, Cranmer Terrace, London SW17 0RE, UK.
Eur Heart J Cardiovasc Imaging ; 25(6): 764-770, 2024 May 31.
Article em En | MEDLINE | ID: mdl-38412329
ABSTRACT

AIMS:

Previously, we demonstrated that inferolateral mitral annular disjunction (MAD) is more prevalent in patients with idiopathic ventricular fibrillation (IVF) than in healthy controls. In the present study, we advanced the insights into the prevalence and ventricular arrhythmogenicity by inferolateral MAD in an even larger IVF cohort. METHODS AND

RESULTS:

This retrospective multi-centre study included 185 IVF patients [median age 39 (27, 52) years, 40% female]. Cardiac magnetic resonance images were analyzed for mitral valve and annular abnormalities and late gadolinium enhancement. Clinical characteristics were compared between patients with and without MAD. MAD in any of the 4 locations was present in 112 (61%) IVF patients and inferolateral MAD was identified in 24 (13%) IVF patients. Mitral valve prolapse (MVP) was found in 13 (7%) IVF patients. MVP was more prevalent in patients with inferolateral MAD compared with patients without inferolateral MAD (42 vs. 2%, P < 0.001). Pro-arrhythmic characteristics in terms of a high burden of premature ventricular complexes (PVCs) and non-sustained ventricular tachycardia (VT) were more prevalent in patients with inferolateral MAD compared to patients without inferolateral MAD (67 vs. 23%, P < 0.001 and 63 vs. 41%, P = 0.046, respectively). Appropriate implantable cardioverter defibrillator therapy during follow-up was comparable for IVF patients with or without inferolateral MAD (13 vs. 18%, P = 0.579).

CONCLUSION:

A high prevalence of inferolateral MAD and MVP is a consistent finding in this large IVF cohort. The presence of inferolateral MAD is associated with a higher PVC burden and non-sustained VTs. Further research is needed to explain this potential interplay.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Ventricular Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Ventricular Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article